Poly ADP ribose polymerase (PARP) for the treatment of BRCA-mutated advanced ovarian cancer

被引:0
|
作者
Yunokawa, Mayu [1 ]
机构
[1] JFCR, Canc Inst Hosp, Gynecol Oncol & Med Oncol Dept, Tokyo, Japan
关键词
D O I
10.1093/annonc/mdz336.001
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
MS3 - 4
引用
收藏
页码:47 / 47
页数:1
相关论文
共 50 条
  • [1] Rucaparib: A Poly(ADP-Ribose) Polymerase Inhibitor for BRCA-Mutated Relapsed Ovarian Cancer
    Moore, Donald C.
    Ringley, J. Tanner
    Patel, Jolly
    JOURNAL OF PHARMACY PRACTICE, 2019, 32 (02) : 219 - 224
  • [2] Development of Poly(ADP-Ribose) Polymerase Inhibitors in the Treatment of BRCA-Mutated Breast Cancer
    Sulai, Nanna H.
    Tan, Antoinette R.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2018, 16 (07) : 491 - 501
  • [3] Modulatory Potential of Poly (ADP-Ribose) Polymerase 1 (PARP1) in BRCA-Mutated Tumors
    Munyembaraga, Valens
    Cyuzuzo, Delphine
    Dao, Tran Nhat Phong
    Oyinloye, Babatunji Emmanuel
    Onikanni, Sunday Amos
    Chang, Hen-Hong
    EUROPEAN JOURNAL OF CANCER CARE, 2024, 2024
  • [4] Poly(ADP-ribose) polymerase (PARP) inhibitors for the treatment of ovarian cancer
    Wiggans, Alison J.
    Cass, Gemma K. S.
    Bryant, Andrew
    Lawrie, Theresa A.
    Morrison, Jo
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2015, (05):
  • [5] Olaparib for the treatment of BRCA-mutated advanced ovarian cancer
    Munroe, Marklie
    Kolesar, Jill
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2016, 73 (14) : 1037 - 1041
  • [6] Poly(ADP-ribose) polymerase (PARP) inhibitors for the treatment of ovarian cancer (Review)
    Wiggans, Alison J.
    Cass, Gemma K. S.
    Bryant, Andrew
    Lawrie, Theresa A.
    Morrison, Jo
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2022, (02):
  • [7] Poly(ADP-ribose) polymerase (PARP) inhibitors and ovarian cancer
    Liu, Chia-Hao
    Chang, Yi
    Wang, Peng-Hui
    TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY, 2017, 56 (05): : 713 - 714
  • [8] Role of BRCA Mutations in Cancer Treatment with Poly(ADP-ribose) Polymerase (PARP) Inhibitors
    Faraoni, Isabella
    Graziani, Grazia
    CANCERS, 2018, 10 (12):
  • [9] PSPC1 Inhibition Synergizes with Poly(ADP-ribose) Polymerase Inhibitors in a Preclinical Model of BRCA-Mutated Breast/Ovarian Cancer
    Ghosh, Mithun
    Kang, Min Sil
    Katuwal, Nar Bahadur
    Hong, Sa Deok
    Jeong, Yeong Gyu
    Park, Seong Min
    Kim, Seul-Gi
    Moon, Yong Wha
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (23)
  • [10] Olaparib for BRCA-mutated advanced ovarian cancer
    de Lartigue, Jane
    JOURNAL OF COMMUNITY AND SUPPORTIVE ONCOLOGY, 2015, 13 (06): : 206 - 208